Report Detail

Medical Devices & Consumables Global Microneedle Transdermal Drug Delivery System Market Research Report 2021

  • RnM4268773
  • |
  • 06 April, 2021
  • |
  • Global
  • |
  • 123 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Hollow Type
Solid Type
Soluble Type

Segment by Application
Drug
Vaccine

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
3 M
Zosano Pharma
Becton-Dickinson(BD)Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect, Inc
Vaxxas
Lohmann Therapie-Systeme AG


1 Microneedle Transdermal Drug Delivery System Market Overview

  • 1.1 Product Overview and Scope of Microneedle Transdermal Drug Delivery System
  • 1.2 Microneedle Transdermal Drug Delivery System Segment by Type
    • 1.2.1 Global Microneedle Transdermal Drug Delivery System Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Hollow Type
    • 1.2.3 Solid Type
    • 1.2.4 Soluble Type
  • 1.3 Microneedle Transdermal Drug Delivery System Segment by Application
    • 1.3.1 Microneedle Transdermal Drug Delivery System Sales Comparison by Application: (2021-2027)
    • 1.3.2 Drug
    • 1.3.3 Vaccine
  • 1.4 Global Microneedle Transdermal Drug Delivery System Market Size Estimates and Forecasts
    • 1.4.1 Global Microneedle Transdermal Drug Delivery System Revenue 2016-2027
    • 1.4.2 Global Microneedle Transdermal Drug Delivery System Sales 2016-2027
    • 1.4.3 Microneedle Transdermal Drug Delivery System Market Size by Region: 2016 Versus 2021 Versus 2027

2 Microneedle Transdermal Drug Delivery System Market Competition by Manufacturers

  • 2.1 Global Microneedle Transdermal Drug Delivery System Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Microneedle Transdermal Drug Delivery System Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Microneedle Transdermal Drug Delivery System Manufacturing Sites, Area Served, Product Type
  • 2.5 Microneedle Transdermal Drug Delivery System Market Competitive Situation and Trends
    • 2.5.1 Microneedle Transdermal Drug Delivery System Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Microneedle Transdermal Drug Delivery System Players Market Share by Revenue
    • 2.5.3 Global Microneedle Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Microneedle Transdermal Drug Delivery System Retrospective Market Scenario by Region

  • 3.1 Global Microneedle Transdermal Drug Delivery System Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Microneedle Transdermal Drug Delivery System Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
    • 3.3.1 North America Microneedle Transdermal Drug Delivery System Sales by Country
    • 3.3.2 North America Microneedle Transdermal Drug Delivery System Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
    • 3.4.1 Europe Microneedle Transdermal Drug Delivery System Sales by Country
    • 3.4.2 Europe Microneedle Transdermal Drug Delivery System Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Microneedle Transdermal Drug Delivery System Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Microneedle Transdermal Drug Delivery System Sales by Region
    • 3.5.2 Asia Pacific Microneedle Transdermal Drug Delivery System Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
    • 3.6.1 Latin America Microneedle Transdermal Drug Delivery System Sales by Country
    • 3.6.2 Latin America Microneedle Transdermal Drug Delivery System Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Microneedle Transdermal Drug Delivery System Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Microneedle Transdermal Drug Delivery System Sales by Country
    • 3.7.2 Middle East and Africa Microneedle Transdermal Drug Delivery System Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Microneedle Transdermal Drug Delivery System Historic Market Analysis by Type

  • 4.1 Global Microneedle Transdermal Drug Delivery System Sales Market Share by Type (2016-2021)
  • 4.2 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Type (2016-2021)
  • 4.3 Global Microneedle Transdermal Drug Delivery System Price by Type (2016-2021)

5 Global Microneedle Transdermal Drug Delivery System Historic Market Analysis by Application

  • 5.1 Global Microneedle Transdermal Drug Delivery System Sales Market Share by Application (2016-2021)
  • 5.2 Global Microneedle Transdermal Drug Delivery System Revenue Market Share by Application (2016-2021)
  • 5.3 Global Microneedle Transdermal Drug Delivery System Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 3 M
    • 6.1.1 3 M Corporation Information
    • 6.1.2 3 M Description and Business Overview
    • 6.1.3 3 M Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 3 M Product Portfolio
    • 6.1.5 3 M Recent Developments/Updates
  • 6.2 Zosano Pharma
    • 6.2.1 Zosano Pharma Corporation Information
    • 6.2.2 Zosano Pharma Description and Business Overview
    • 6.2.3 Zosano Pharma Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Zosano Pharma Product Portfolio
    • 6.2.5 Zosano Pharma Recent Developments/Updates
  • 6.3 Becton-Dickinson(BD)Technologies
    • 6.3.1 Becton-Dickinson(BD)Technologies Corporation Information
    • 6.3.2 Becton-Dickinson(BD)Technologies Description and Business Overview
    • 6.3.3 Becton-Dickinson(BD)Technologies Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Becton-Dickinson(BD)Technologies Product Portfolio
    • 6.3.5 Becton-Dickinson(BD)Technologies Recent Developments/Updates
  • 6.4 Nanopass Technologies
    • 6.4.1 Nanopass Technologies Corporation Information
    • 6.4.2 Nanopass Technologies Description and Business Overview
    • 6.4.3 Nanopass Technologies Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Nanopass Technologies Product Portfolio
    • 6.4.5 Nanopass Technologies Recent Developments/Updates
  • 6.5 Corium
    • 6.5.1 Corium Corporation Information
    • 6.5.2 Corium Description and Business Overview
    • 6.5.3 Corium Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Corium Product Portfolio
    • 6.5.5 Corium Recent Developments/Updates
  • 6.6 Valeritas
    • 6.6.1 Valeritas Corporation Information
    • 6.6.2 Valeritas Description and Business Overview
    • 6.6.3 Valeritas Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Valeritas Product Portfolio
    • 6.6.5 Valeritas Recent Developments/Updates
  • 6.7 Nitto
    • 6.6.1 Nitto Corporation Information
    • 6.6.2 Nitto Description and Business Overview
    • 6.6.3 Nitto Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Nitto Product Portfolio
    • 6.7.5 Nitto Recent Developments/Updates
  • 6.8 Microdermics
    • 6.8.1 Microdermics Corporation Information
    • 6.8.2 Microdermics Description and Business Overview
    • 6.8.3 Microdermics Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Microdermics Product Portfolio
    • 6.8.5 Microdermics Recent Developments/Updates
  • 6.9 TheraJect, Inc
    • 6.9.1 TheraJect, Inc Corporation Information
    • 6.9.2 TheraJect, Inc Description and Business Overview
    • 6.9.3 TheraJect, Inc Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 TheraJect, Inc Product Portfolio
    • 6.9.5 TheraJect, Inc Recent Developments/Updates
  • 6.10 Vaxxas
    • 6.10.1 Vaxxas Corporation Information
    • 6.10.2 Vaxxas Description and Business Overview
    • 6.10.3 Vaxxas Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Vaxxas Product Portfolio
    • 6.10.5 Vaxxas Recent Developments/Updates
  • 6.11 Lohmann Therapie-Systeme AG
    • 6.11.1 Lohmann Therapie-Systeme AG Corporation Information
    • 6.11.2 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Description and Business Overview
    • 6.11.3 Lohmann Therapie-Systeme AG Microneedle Transdermal Drug Delivery System Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Lohmann Therapie-Systeme AG Product Portfolio
    • 6.11.5 Lohmann Therapie-Systeme AG Recent Developments/Updates

7 Microneedle Transdermal Drug Delivery System Manufacturing Cost Analysis

  • 7.1 Microneedle Transdermal Drug Delivery System Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Microneedle Transdermal Drug Delivery System
  • 7.4 Microneedle Transdermal Drug Delivery System Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Microneedle Transdermal Drug Delivery System Distributors List
  • 8.3 Microneedle Transdermal Drug Delivery System Customers

9 Microneedle Transdermal Drug Delivery System Market Dynamics

  • 9.1 Microneedle Transdermal Drug Delivery System Industry Trends
  • 9.2 Microneedle Transdermal Drug Delivery System Growth Drivers
  • 9.3 Microneedle Transdermal Drug Delivery System Market Challenges
  • 9.4 Microneedle Transdermal Drug Delivery System Market Restraints

10 Global Market Forecast

  • 10.1 Microneedle Transdermal Drug Delivery System Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Microneedle Transdermal Drug Delivery System by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Microneedle Transdermal Drug Delivery System by Type (2022-2027)
  • 10.2 Microneedle Transdermal Drug Delivery System Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Microneedle Transdermal Drug Delivery System by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Microneedle Transdermal Drug Delivery System by Application (2022-2027)
  • 10.3 Microneedle Transdermal Drug Delivery System Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Microneedle Transdermal Drug Delivery System by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Microneedle Transdermal Drug Delivery System by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Microneedle Transdermal Drug Delivery System. Industry analysis & Market Report on Microneedle Transdermal Drug Delivery System is a syndicated market report, published as Global Microneedle Transdermal Drug Delivery System Market Research Report 2021. It is complete Research Study and Industry Analysis of Microneedle Transdermal Drug Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,328.70
    3,493.05
    4,657.40
    2,726.00
    4,089.00
    5,452.00
    446,832.00
    670,248.00
    893,664.00
    242,179.00
    363,268.50
    484,358.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report